Logo image of CBPO

China Biologic Produ (CBPO) Stock Overview

USA - NASDAQ:CBPO -

119.99
+1.98 (+1.68%)
Last: 4/20/2021, 8:09:52 PM
120.04
+0.05 (+0.04%)
After Hours: 4/20/2021, 8:09:52 PM

CBPO Key Statistics, Chart & Performance

Key Statistics
Market Cap4.72B
Revenue(TTM)524.37M
Net Income(TTM)152.29M
Shares39.36M
Float31.41M
52 Week High120.05
52 Week Low99.74
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)3.99
PE30.07
Fwd PE27.9
Earnings (Next)N/A N/A
IPON/A
Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A


CBPO short term performance overview.The bars show the price performance of CBPO in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 2 4 6

CBPO long term performance overview.The bars show the price performance of CBPO in the last 1, 2 and 3 years. 1 year 2 years 3 years 2 4 6 8 10

The current stock price of CBPO is 119.99 null. In the past month the price increased by 2.25%. In the past year, price increased by 12.37%.

China Biologic Produ / CBPO Daily stock chart

CBPO Latest News, Press Relases and Analysis

About CBPO

Company Profile

China Biologic Products, Inc., through its indirect majority-owned subsidiary, is principally engaged in the research, development, production, manufacturing and sale of plasma-based biopharmaceutical products to hospitals and other health care facilities in China. Its subsidiary, Shandong Taibang Biological Products Co. Ltd., operates from its manufacturing facility located in Taian City, Shandong Province. The Company's principal products include its approved human albumin and immunoglobulin products. These human albumin products are mainly used to increase blood volume and its immunoglobulin products are used for the treatment and prevention of diseases.

Company Info

China Biologic Produ

18TH FL JIALONG INTERNATIONALBUILDING 19 CHAOYANG PARK ROAD CHAOYANG DISTRICT

BEIJING F4 100125

CEO: Joseph Chow

Phone: 86-10-6598-3111

China Biologic Produ / CBPO FAQ

Can you describe the business of China Biologic Produ?

China Biologic Products, Inc., through its indirect majority-owned subsidiary, is principally engaged in the research, development, production, manufacturing and sale of plasma-based biopharmaceutical products to hospitals and other health care facilities in China. Its subsidiary, Shandong Taibang Biological Products Co. Ltd., operates from its manufacturing facility located in Taian City, Shandong Province. The Company's principal products include its approved human albumin and immunoglobulin products. These human albumin products are mainly used to increase blood volume and its immunoglobulin products are used for the treatment and prevention of diseases.


What is the current price of CBPO stock?

The current stock price of CBPO is 119.99 null. The price increased by 1.68% in the last trading session.


Does China Biologic Produ pay dividends?

CBPO does not pay a dividend.


What is the ChartMill rating of China Biologic Produ stock?

CBPO has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


Who owns China Biologic Produ?

You can find the ownership structure of China Biologic Produ (CBPO) on the Ownership tab.


CBPO Technical Analysis

ChartMill assigns a technical rating of 5 / 10 to CBPO. When comparing the yearly performance of all stocks, CBPO is a bad performer in the overall market: 77.21% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

CBPO Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to CBPO. While CBPO has a great health rating, its profitability is only average at the moment.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

CBPO Financial Highlights

Over the last trailing twelve months CBPO reported a non-GAAP Earnings per Share(EPS) of 3.99. The EPS decreased by -6.78% compared to the year before.


Industry RankSector Rank
PM (TTM) 29.04%
ROA 7.12%
ROE 7.71%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-25.71%
Sales Q2Q%1.78%
EPS 1Y (TTM)-6.78%
Revenue 1Y (TTM)4.09%

CBPO Forecast & Estimates


Analysts
Analysts0
Price TargetN/A
EPS Next Y7.77%
Revenue Next YearN/A

CBPO Ownership

Ownership
Inst Owners7.62%
Ins Owners39.98%
Short Float %N/A
Short RatioN/A